Associate Professor, Neurology, Emory University School of Medicine
Neurology
Dr. Jorge L. Juncos, MD
|
|
Give Review
Jorge L. Juncos works in the field of Neurology. He graduated from Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care Doctor Jorge L. Juncos, MD is a published doctor. He has 77 publications published. The most current publication "Depression and disability in Parkinson's disease." Jorge L. Juncos accepts Medicare.
Publications
- Environmental and Occupational Risk Factors for Progressive Supranuclear Palsy: Case-Control Study.
- Tourette syndrome deep Brain stimulation: A review and updated recommendations.
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit.
- Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's Disease.
- The effect of Tai Chi exercise on gait initiation and gait performance in persons with Parkinson's Disease.
- Nocturia and overnight polysomnography in Parkinson Disease.
- New clinical findings in the fragile X-associated tremor Ataxia syndrome (FXTAS).
- Progressive supranuclear Palsy: a current review.
- Resistance training with creatine monohydrate improves upper-body strength in patients with Parkinson Disease: a randomized trial.
- Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's Disease.
- Gait initiation and dynamic balance control in Parkinson's Disease.
- Quetiapine improves psychotic symptoms and cognition in Parkinson's Disease.
- Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson Disease.
- Aggregation of actin and cofilin in identical twins with juvenile-onset Dystonia.
- Parkinson's and Alzheimer's Diseases in Costa Rica: a feasibility study toward a national screening program.
- Huntington's Disease: effect of cysteamine, a somatostatin-depleting agent.
- Cholecystokinin-mediated synaptic function and the treatment of neuropsychiatric Disease.
- Detection of early FXTAS motor symptoms using the CATSYS computerised neuromotor test battery.
- Fluctuating levodopa concentrations and Parkinson''s Disease.
- Dorsal subthalamotomy for Parkinson's Disease.
- Fluctuation in response to chronic levodopa therapy: pathogenetic and therapeutic considerations.
- Selective deficits in cognition and memory in high-functioning parkinsonian patients.
- Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's Disease.
- A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia.
- Patient selection and assessment recommendations for deep Brain stimulation in Tourette syndrome.
- A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and Dystonia.
- Measuring the effects of therapy in Parkinson Disease.
- Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric Disorders".
- Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson''s Disease.
- Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome.
- Gait initiation in older adults with postural instability.
- Chronic dopaminergic stimulation in Parkinson''s Disease: from dyskinesias to impulse control disorders.
- Effects of coenzyme Q10 in early Parkinson Disease: evidence of slowing of the functional decline.
- Benefits and risks of pharmacological treatments for Essential tremor.
- Complications of gamma knife surgery for Parkinson Disease.
- Lesion of the basal ganglia and surgery for Parkinson Disease.
- Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's Disease with N-0923 TDS: a double-blind, placebo-controlled study.
- Motor response complications in advanced Parkinson''s Disease.
- Pathogenetic studies of motor fluctuations in Parkinson''s Disease.
- Management of psychotic aspects of Parkinson's Disease.
- Depression and disability in Parkinson's Disease.
- Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.
- Individual differences in schedule-induced and conditioned behaviors.
- Effects of cocaine microinjections into the nucleus accumbens and medial prefrontal cortex on schedule-induced behaviour: comparison with systemic cocaine administration.
- Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
- Idiopathic cranial Polyneuropathy. A fifteen-year experience.
- Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations.
- Dietary influences on the antiparkinsonian response to levodopa.
- Levodopa methyl ester treatment of Parkinson's Disease.
- Pathogenesis of dyskinesias in Parkinson's Disease.
- Continuous and intermittent levodopa differentially affect basal ganglia function.
- Rationale for continuous dopaminomimetic therapy of Parkinson's Disease.
- Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists.
- 3-O-methyldopa and motor fluctuations in Parkinson's Disease.
- Controlled release levodopa treatment of motor fluctuations in Parkinson''s Disease.
- Exercise and the antiparkinsonian response to levodopa.
- Motor fluctuations in Parkinson's Disease: pathogenetic and therapeutic studies.
- Dopaminergic effects on simple and choice reaction time performance in Parkinson's Disease.
- Motor fluctuations in Parkinson's Disease: central pathophysiological mechanisms, Part II.
- Motor fluctuations in Parkinson's Disease: central pathophysiological mechanisms, Part I.
- Movement amplitude choice reaction time performance in Parkinson''s Disease may be independent of dopaminergic status.
- Anxiety disorders in patients with Parkinson's Disease.
- Motor response complications with chronic levodopa therapy.
- Mesencephalic cholinergic nuclei in progressive supranuclear Palsy.
- Mitochondrial oxidative phosphorylation defects in Parkinson's Disease.
- Clozapine is beneficial for psychosis in Parkinson's Disease.
- Electrophysiologic analysis of early Parkinson's Disease.
- Levodopa: pharmacology, pharmacokinetics, and pharmacodynamics.
- Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis.
- A pilot study examining the effects of neuromuscular therapy on patients with Parkinson''s Disease.
- Bilateral subthalamotomy in Parkinson''s Disease: initial and long-term response.
- Clinical and neuropathologic variation in neuronal intermediate filament inclusion Disease.
- Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus.
- Behavioral therapy to treat urinary incontinence in Parkinson Disease.
- Therapeutic efficacy of unilateral subthalamotomy in Parkinson''s Disease: results in 89 patients followed for up to 36 months.
- Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/Ataxia syndrome.
Schools
Columbia University College of Physicians And Surgeons
Clinical Center At The Nih
Mass Gen Hospital
St Luke39s Roosevelt H Roosevel
Procedures Preformed
- EEG (Electroencephalogram)
- Nerve Block, Somatic
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Brachial Plexus Palsy
- View All
Doctors Specialties
- Internal Medicine
- Neurology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Massachusetts General Hospital -
St Luke's-Roosevelt Hospital Center -
Columbia University College of Physicians & Surgeons
Hospital
-
Emory University Hospital -
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1184801383 | |
| NPPES Provider LastName | JUNCOS | |
| NPPES Provider FirstName | JORGE | |
| NPPES Provider ZIPCode | 303294021 | |
| NPPES Provider State | GA | |
| Specialty Description | Neurology | |
| Total Claim Count | 2959.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184801383 |
| Last Name Of The Provider | JUNCOS |
| First Name Of The Provider | JORGE |
| View All |
Similar Doctors
|
|
Dr. Terry W. Wood, MD |
|
|
Dr. Richard D. Kaplan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruth M. Parker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stewart A. Factor, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gavin F. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela Ashley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick A. Griffith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Elsner, MD |
|
|
Dr. Christina L. Mayville, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amena M. Imtiaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James J. Sejvar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edith E. Biggers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime M. Hatcher Martin, MD |
|
|
Dr. Alfredo D. Voloschin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olivia A. Groover, MD |
|
|
Dr. Shawnay N. Mazell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iesha Galloway, MD
This Doctor is OpenDoctor Recommended.
|